Filing Flows › Doximity (DOCS) › R&D spending
Doximity (DOCS) R&D spending by quarter
Doximity's R&D spending was $42.0M in Q2 FY27 (second quarter fiscal 2027), +9% from Q1 FY27. Over the last 7 quarters it ranged from $24.8M (Q4 FY25) to $42.0M (Q2 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $42.0M | +9% | +39% |
| Q1 FY27 | $38.5M | -2% | +44% |
| Q4 FY26 | $39.1M | +13% | +58% |
| Q3 FY26 | $34.6M | +15% | — |
| Q2 FY26 | $30.2M | +13% | — |
| Q1 FY26 | $26.8M | +8% | — |
| Q4 FY25 | $24.8M | — | — |
Q2 FY27 at a glance
Doximity, Q2 FY27: revenue $175M (+4% year over year), operating margin 25.2%, net earnings $34.7M, operating cash flow $93.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Doximity's R&D spending?
Doximity's R&D spending was $42.0M in Q2 FY27 (second quarter fiscal 2027), +9% from Q1 FY27.
How has Doximity's R&D spending changed?
Over the last 7 quarters it ranged from $24.8M (Q4 FY25) to $42.0M (Q2 FY27).